Philippa Marrack
Concepts (898)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 228 | 2021 | 1913 | 8.510 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 64 | 2024 | 332 | 5.230 |
Why?
| Receptors, Antigen, T-Cell | 114 | 2024 | 703 | 5.040 |
Why?
| Lymphocyte Activation | 76 | 2020 | 1094 | 4.650 |
Why?
| Major Histocompatibility Complex | 58 | 2024 | 229 | 4.330 |
Why?
| CD4-Positive T-Lymphocytes | 42 | 2024 | 1044 | 4.200 |
Why?
| B-Lymphocytes | 65 | 2018 | 813 | 4.100 |
Why?
| Thymus Gland | 61 | 2024 | 307 | 3.970 |
Why?
| Histocompatibility Antigens Class II | 74 | 2021 | 361 | 3.860 |
Why?
| Autoimmunity | 17 | 2023 | 861 | 3.570 |
Why?
| Adjuvants, Immunologic | 14 | 2017 | 219 | 3.570 |
Why?
| CD8-Positive T-Lymphocytes | 25 | 2021 | 833 | 3.070 |
Why?
| Immunologic Memory | 28 | 2020 | 337 | 3.000 |
Why?
| Histocompatibility Antigens | 18 | 2019 | 108 | 2.730 |
Why?
| Mice | 320 | 2024 | 16583 | 2.630 |
Why?
| Animals | 366 | 2024 | 34708 | 2.400 |
Why?
| T-Lymphocyte Subsets | 22 | 2018 | 411 | 2.080 |
Why?
| B-Lymphocyte Subsets | 8 | 2020 | 75 | 2.030 |
Why?
| Peptides | 43 | 2021 | 904 | 2.010 |
Why?
| Antigens | 40 | 2020 | 348 | 1.980 |
Why?
| Alum Compounds | 7 | 2017 | 22 | 1.920 |
Why?
| Proto-Oncogene Proteins | 13 | 2009 | 638 | 1.860 |
Why?
| Apoptosis | 18 | 2018 | 2485 | 1.830 |
Why?
| Mice, Inbred C57BL | 107 | 2024 | 5282 | 1.750 |
Why?
| Immune Tolerance | 30 | 2021 | 349 | 1.640 |
Why?
| Toll-Like Receptor 7 | 5 | 2016 | 37 | 1.540 |
Why?
| T-Box Domain Proteins | 7 | 2020 | 96 | 1.530 |
Why?
| Dendritic Cells | 11 | 2017 | 478 | 1.500 |
Why?
| Hybridomas | 73 | 2019 | 234 | 1.490 |
Why?
| Apoptosis Regulatory Proteins | 11 | 2011 | 181 | 1.460 |
Why?
| Enterotoxins | 26 | 2009 | 89 | 1.440 |
Why?
| Mice, Transgenic | 44 | 2024 | 2082 | 1.370 |
Why?
| Aging | 11 | 2018 | 1773 | 1.340 |
Why?
| Autoimmune Diseases | 11 | 2021 | 421 | 1.290 |
Why?
| Membrane Proteins | 12 | 2020 | 1102 | 1.250 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 13 | 2007 | 229 | 1.240 |
Why?
| Autoantigens | 18 | 2021 | 414 | 1.230 |
Why?
| Superantigens | 20 | 2019 | 71 | 1.230 |
Why?
| Antigen-Presenting Cells | 21 | 2015 | 151 | 1.220 |
Why?
| H-2 Antigens | 38 | 2011 | 114 | 1.180 |
Why?
| CD11c Antigen | 5 | 2020 | 40 | 1.160 |
Why?
| Antigen Presentation | 16 | 2017 | 205 | 1.090 |
Why?
| Antigens, Surface | 24 | 2011 | 151 | 1.040 |
Why?
| Peptide Fragments | 18 | 2021 | 694 | 1.030 |
Why?
| Amino Acid Sequence | 65 | 2019 | 2050 | 1.020 |
Why?
| Immunity, Cellular | 15 | 2010 | 267 | 1.020 |
Why?
| Spleen | 27 | 2016 | 518 | 1.000 |
Why?
| Vaccines | 4 | 2017 | 403 | 1.000 |
Why?
| Herpesviridae Infections | 3 | 2017 | 142 | 0.990 |
Why?
| Immune System | 7 | 2013 | 175 | 0.980 |
Why?
| Berylliosis | 5 | 2020 | 187 | 0.970 |
Why?
| Protein Binding | 31 | 2021 | 2087 | 0.950 |
Why?
| Autoantibodies | 7 | 2023 | 1464 | 0.920 |
Why?
| Mammary Tumor Virus, Mouse | 12 | 1995 | 42 | 0.920 |
Why?
| Interleukin-12 | 2 | 2016 | 118 | 0.920 |
Why?
| Interleukin-2 | 38 | 2015 | 428 | 0.920 |
Why?
| Epitopes | 46 | 2021 | 469 | 0.910 |
Why?
| Antigens, Viral | 10 | 2001 | 181 | 0.900 |
Why?
| Clone Cells | 18 | 2008 | 258 | 0.900 |
Why?
| Signal Transduction | 21 | 2018 | 4867 | 0.900 |
Why?
| Interferon-gamma | 13 | 2016 | 759 | 0.890 |
Why?
| Molecular Sequence Data | 60 | 2015 | 2846 | 0.870 |
Why?
| Gene Expression Regulation | 21 | 2015 | 2523 | 0.870 |
Why?
| Immunoglobulin G | 8 | 2017 | 837 | 0.770 |
Why?
| Cytokines | 16 | 2020 | 1997 | 0.740 |
Why?
| Sarcoidosis, Pulmonary | 2 | 2020 | 74 | 0.730 |
Why?
| Cell Differentiation | 31 | 2018 | 1858 | 0.710 |
Why?
| Cell Survival | 18 | 2009 | 1085 | 0.700 |
Why?
| Antibody Formation | 19 | 2017 | 284 | 0.690 |
Why?
| Carrier Proteins | 11 | 2009 | 731 | 0.690 |
Why?
| Genes, MHC Class II | 19 | 2014 | 72 | 0.670 |
Why?
| Flow Cytometry | 26 | 2015 | 1147 | 0.670 |
Why?
| Aluminum | 2 | 2010 | 38 | 0.660 |
Why?
| Mice, Inbred BALB C | 48 | 2021 | 1230 | 0.660 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 96 | 0.660 |
Why?
| Lymphocytes | 5 | 2018 | 369 | 0.650 |
Why?
| Alleles | 12 | 2017 | 847 | 0.650 |
Why?
| Obsessive-Compulsive Disorder | 1 | 2019 | 42 | 0.640 |
Why?
| Ovalbumin | 23 | 2011 | 179 | 0.640 |
Why?
| Cell Death | 15 | 2019 | 344 | 0.630 |
Why?
| Mice, Knockout | 20 | 2017 | 2774 | 0.630 |
Why?
| Antibodies, Monoclonal | 53 | 2016 | 1361 | 0.630 |
Why?
| Mice, Inbred Strains | 36 | 2000 | 407 | 0.630 |
Why?
| bcl-2-Associated X Protein | 5 | 2006 | 49 | 0.630 |
Why?
| Natural Killer T-Cells | 6 | 2018 | 64 | 0.610 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 642 | 0.600 |
Why?
| CD8 Antigens | 10 | 2013 | 75 | 0.600 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 822 | 0.590 |
Why?
| Thymocytes | 3 | 2018 | 30 | 0.590 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2017 | 251 | 0.580 |
Why?
| Cells, Cultured | 27 | 2019 | 4063 | 0.580 |
Why?
| Interleukin-4 | 6 | 2008 | 214 | 0.570 |
Why?
| Disease Susceptibility | 1 | 2019 | 338 | 0.570 |
Why?
| Amino Acids | 5 | 2022 | 470 | 0.570 |
Why?
| Interleukin-15 | 6 | 2013 | 82 | 0.570 |
Why?
| Herpesviridae | 1 | 2017 | 23 | 0.560 |
Why?
| Interleukin-7 | 4 | 2004 | 58 | 0.560 |
Why?
| Cat Diseases | 1 | 2017 | 19 | 0.560 |
Why?
| Epitopes, T-Lymphocyte | 6 | 2021 | 185 | 0.550 |
Why?
| Cell Line | 41 | 2021 | 2762 | 0.540 |
Why?
| Humans | 124 | 2023 | 129079 | 0.540 |
Why?
| Bcl-2-Like Protein 11 | 9 | 2009 | 37 | 0.540 |
Why?
| Membrane Glycoproteins | 6 | 2013 | 465 | 0.530 |
Why?
| Friend murine leukemia virus | 1 | 2016 | 29 | 0.530 |
Why?
| Deoxyribonucleases | 1 | 2016 | 23 | 0.530 |
Why?
| Homeostasis | 5 | 2007 | 605 | 0.530 |
Why?
| Cell Proliferation | 12 | 2020 | 2344 | 0.520 |
Why?
| Ikaros Transcription Factor | 2 | 2013 | 21 | 0.520 |
Why?
| Models, Molecular | 26 | 2018 | 1480 | 0.510 |
Why?
| Complementarity Determining Regions | 6 | 2011 | 49 | 0.510 |
Why?
| Cell Division | 11 | 2008 | 802 | 0.510 |
Why?
| Antigens, Neoplasm | 5 | 2021 | 309 | 0.480 |
Why?
| Antigens, Bacterial | 8 | 2013 | 120 | 0.480 |
Why?
| Reactive Oxygen Species | 3 | 2003 | 578 | 0.480 |
Why?
| Influenza A virus | 2 | 2013 | 104 | 0.480 |
Why?
| Evolution, Molecular | 4 | 2019 | 465 | 0.470 |
Why?
| Histocompatibility Antigens Class I | 10 | 2013 | 196 | 0.460 |
Why?
| Histone Demethylases | 3 | 2020 | 31 | 0.460 |
Why?
| Staphylococcus aureus | 12 | 1999 | 429 | 0.460 |
Why?
| Immunity, Innate | 6 | 2019 | 804 | 0.460 |
Why?
| Protein Conformation | 19 | 2018 | 853 | 0.430 |
Why?
| Models, Immunological | 8 | 2017 | 94 | 0.430 |
Why?
| Clonal Deletion | 4 | 2004 | 16 | 0.430 |
Why?
| Nucleoproteins | 1 | 2013 | 28 | 0.420 |
Why?
| Viral Proteins | 2 | 2009 | 329 | 0.420 |
Why?
| Gammaherpesvirinae | 1 | 2013 | 37 | 0.420 |
Why?
| T-Lymphocytes, Cytotoxic | 5 | 2012 | 166 | 0.420 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 76 | 0.410 |
Why?
| Th2 Cells | 3 | 2010 | 169 | 0.410 |
Why?
| Hypersensitivity | 2 | 2014 | 277 | 0.400 |
Why?
| DNA | 10 | 2016 | 1407 | 0.400 |
Why?
| Mutation | 22 | 2022 | 3679 | 0.400 |
Why?
| Lymphocyte Cooperation | 22 | 2006 | 49 | 0.400 |
Why?
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 102 | 0.390 |
Why?
| Base Sequence | 33 | 2015 | 2157 | 0.390 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 37 | 0.390 |
Why?
| Antibodies | 7 | 2009 | 393 | 0.380 |
Why?
| bcl-X Protein | 4 | 2006 | 41 | 0.380 |
Why?
| Staphylococcus | 5 | 1994 | 74 | 0.380 |
Why?
| Clonal Anergy | 3 | 2006 | 52 | 0.370 |
Why?
| Female | 67 | 2021 | 68274 | 0.370 |
Why?
| Binding Sites | 19 | 2021 | 1239 | 0.370 |
Why?
| Receptors, Cell Surface | 4 | 2020 | 379 | 0.370 |
Why?
| Receptors, Chemokine | 2 | 2008 | 46 | 0.370 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 18 | 0.360 |
Why?
| Lipid A | 1 | 2011 | 29 | 0.360 |
Why?
| Vaccines, Subunit | 1 | 2011 | 47 | 0.360 |
Why?
| Chromosomes, Human, X | 2 | 2015 | 72 | 0.360 |
Why?
| Th1 Cells | 2 | 2010 | 135 | 0.360 |
Why?
| Mast Cells | 2 | 2009 | 142 | 0.350 |
Why?
| Inflammation | 5 | 2020 | 2696 | 0.350 |
Why?
| Germ Cells | 2 | 2016 | 62 | 0.340 |
Why?
| Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.340 |
Why?
| Cell Communication | 9 | 2013 | 293 | 0.340 |
Why?
| Genes | 16 | 1990 | 227 | 0.330 |
Why?
| Gonadal Steroid Hormones | 2 | 2014 | 134 | 0.330 |
Why?
| Nobel Prize | 1 | 2009 | 4 | 0.330 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 14 | 0.330 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 17 | 1991 | 87 | 0.330 |
Why?
| Genetics, Medical | 1 | 2009 | 22 | 0.330 |
Why?
| Macrophages, Peritoneal | 1 | 2009 | 90 | 0.320 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2011 | 50 | 0.320 |
Why?
| Protein Processing, Post-Translational | 7 | 2018 | 448 | 0.320 |
Why?
| Glycoproteins | 3 | 2011 | 340 | 0.320 |
Why?
| HLA-DR Antigens | 8 | 2008 | 226 | 0.310 |
Why?
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 772 | 0.310 |
Why?
| Cytotoxicity, Immunologic | 7 | 2009 | 216 | 0.300 |
Why?
| Receptors, Immunologic | 3 | 2020 | 213 | 0.300 |
Why?
| Cell Movement | 7 | 2017 | 935 | 0.300 |
Why?
| Vaccination | 5 | 2010 | 1351 | 0.300 |
Why?
| Herpesvirus 4, Human | 1 | 2009 | 153 | 0.300 |
Why?
| Binding, Competitive | 8 | 2003 | 208 | 0.290 |
Why?
| Transcription Factors | 5 | 2012 | 1636 | 0.290 |
Why?
| Allergy and Immunology | 2 | 2006 | 60 | 0.290 |
Why?
| CD3 Complex | 8 | 2009 | 100 | 0.280 |
Why?
| Receptors, Interleukin-2 | 4 | 2003 | 65 | 0.280 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 60 | 0.280 |
Why?
| Bone Marrow Cells | 5 | 2016 | 291 | 0.280 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 25 | 0.280 |
Why?
| Genetic Predisposition to Disease | 4 | 2010 | 2273 | 0.270 |
Why?
| HLA-DP beta-Chains | 4 | 2014 | 84 | 0.270 |
Why?
| RNA, Messenger | 11 | 2022 | 2702 | 0.270 |
Why?
| Gene Expression Profiling | 6 | 2018 | 1696 | 0.260 |
Why?
| Histones | 3 | 2018 | 584 | 0.260 |
Why?
| Inflammation Mediators | 1 | 2009 | 503 | 0.260 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2021 | 3604 | 0.260 |
Why?
| Lymph Nodes | 14 | 2015 | 459 | 0.260 |
Why?
| T-Lymphocytes, Helper-Inducer | 10 | 1989 | 137 | 0.260 |
Why?
| Transfection | 16 | 2008 | 907 | 0.250 |
Why?
| Bacterial Toxins | 6 | 1997 | 107 | 0.250 |
Why?
| Lipopolysaccharides | 10 | 2005 | 877 | 0.250 |
Why?
| History, 20th Century | 6 | 2016 | 295 | 0.250 |
Why?
| Antigens, CD1d | 5 | 2013 | 66 | 0.240 |
Why?
| Cross Reactions | 8 | 2012 | 130 | 0.240 |
Why?
| Cytochrome c Group | 5 | 2002 | 42 | 0.240 |
Why?
| Gene Expression | 11 | 2017 | 1477 | 0.240 |
Why?
| Cell Membrane | 6 | 2004 | 729 | 0.240 |
Why?
| Heterozygote | 2 | 2024 | 269 | 0.230 |
Why?
| Mitochondria | 4 | 2008 | 840 | 0.230 |
Why?
| Protein Folding | 1 | 2006 | 263 | 0.230 |
Why?
| Insulin | 4 | 2019 | 2313 | 0.230 |
Why?
| Repressor Proteins | 2 | 2015 | 400 | 0.230 |
Why?
| Immunoglobulin Variable Region | 11 | 2012 | 79 | 0.230 |
Why?
| Baculoviridae | 7 | 2015 | 44 | 0.230 |
Why?
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.230 |
Why?
| Beryllium | 3 | 2014 | 154 | 0.230 |
Why?
| NF-kappa B | 3 | 2017 | 687 | 0.230 |
Why?
| Interleukin-6 | 3 | 2011 | 716 | 0.220 |
Why?
| Neoplasms, Experimental | 3 | 2021 | 168 | 0.220 |
Why?
| Lymphokines | 13 | 1984 | 126 | 0.220 |
Why?
| Cell Separation | 12 | 2008 | 312 | 0.220 |
Why?
| Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 15 | 0.210 |
Why?
| Crystallography, X-Ray | 9 | 2018 | 437 | 0.210 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2020 | 29 | 0.210 |
Why?
| Lysosomes | 2 | 2021 | 139 | 0.210 |
Why?
| Genes, bcl-2 | 1 | 2002 | 21 | 0.210 |
Why?
| Chromogranin A | 2 | 2015 | 42 | 0.200 |
Why?
| Oligopeptides | 2 | 2001 | 256 | 0.200 |
Why?
| Chemokine CCL5 | 1 | 2002 | 44 | 0.200 |
Why?
| Clodronic Acid | 1 | 2002 | 12 | 0.200 |
Why?
| beta 2-Microglobulin | 4 | 2010 | 49 | 0.200 |
Why?
| Anemia, Hemolytic, Autoimmune | 1 | 2002 | 15 | 0.200 |
Why?
| Ubiquitin-Protein Ligases | 3 | 2008 | 156 | 0.200 |
Why?
| Cloning, Molecular | 13 | 2017 | 536 | 0.200 |
Why?
| Radiation Chimera | 4 | 2001 | 29 | 0.200 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2017 | 377 | 0.200 |
Why?
| Polymorphism, Genetic | 6 | 2012 | 642 | 0.190 |
Why?
| Cell Culture Techniques | 2 | 2001 | 350 | 0.190 |
Why?
| Egg Proteins | 1 | 2001 | 19 | 0.190 |
Why?
| Concanavalin A | 17 | 1990 | 75 | 0.190 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 2002 | 87 | 0.190 |
Why?
| Ligands | 9 | 2022 | 616 | 0.190 |
Why?
| Moloney murine leukemia virus | 1 | 2001 | 12 | 0.190 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 750 | 0.190 |
Why?
| Mice, Mutant Strains | 7 | 2008 | 292 | 0.190 |
Why?
| Lung Diseases | 2 | 2010 | 755 | 0.190 |
Why?
| Transcription, Genetic | 7 | 2020 | 1409 | 0.190 |
Why?
| Interferon-alpha | 4 | 2014 | 191 | 0.190 |
Why?
| Open Reading Frames | 3 | 1992 | 123 | 0.190 |
Why?
| Protein Structure, Tertiary | 8 | 2021 | 835 | 0.180 |
Why?
| Transduction, Genetic | 1 | 2001 | 128 | 0.180 |
Why?
| B7-1 Antigen | 3 | 2004 | 59 | 0.180 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 113 | 0.180 |
Why?
| Cathepsins | 1 | 2021 | 24 | 0.180 |
Why?
| Receptors, Fc | 2 | 2020 | 49 | 0.180 |
Why?
| Immunoglobulin Idiotypes | 7 | 1986 | 27 | 0.180 |
Why?
| Macromolecular Substances | 16 | 2003 | 212 | 0.180 |
Why?
| HLA-C Antigens | 1 | 2021 | 35 | 0.180 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 395 | 0.180 |
Why?
| Macrophages | 18 | 2002 | 1456 | 0.180 |
Why?
| Chimera | 8 | 2009 | 60 | 0.180 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2006 | 1204 | 0.180 |
Why?
| Immunity | 3 | 2007 | 132 | 0.180 |
Why?
| Self Tolerance | 3 | 2017 | 27 | 0.180 |
Why?
| Immunity, Humoral | 2 | 2022 | 118 | 0.180 |
Why?
| Genetic Vectors | 2 | 2001 | 312 | 0.180 |
Why?
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 10 | 0.180 |
Why?
| Models, Animal | 1 | 2002 | 371 | 0.180 |
Why?
| Hematopoietic Stem Cells | 4 | 2014 | 378 | 0.180 |
Why?
| HLA-DQ Antigens | 2 | 2019 | 180 | 0.170 |
Why?
| RNA Polymerase II | 2 | 2020 | 313 | 0.170 |
Why?
| Interferon-beta | 3 | 2007 | 88 | 0.170 |
Why?
| Sex Characteristics | 3 | 2015 | 724 | 0.170 |
Why?
| Mice, Inbred NOD | 7 | 2019 | 579 | 0.170 |
Why?
| Kidney | 2 | 2017 | 1330 | 0.170 |
Why?
| Disease Models, Animal | 6 | 2014 | 3999 | 0.170 |
Why?
| Lymphocytic choriomeningitis virus | 2 | 2011 | 22 | 0.170 |
Why?
| Transcription Factor AP-1 | 1 | 2000 | 85 | 0.170 |
Why?
| Genome | 2 | 2000 | 276 | 0.170 |
Why?
| Receptors, Complement 3d | 1 | 2020 | 140 | 0.160 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 264 | 0.160 |
Why?
| Vaccinia | 1 | 1999 | 22 | 0.160 |
Why?
| Peptide Library | 4 | 2013 | 87 | 0.160 |
Why?
| Methyltransferases | 1 | 2020 | 72 | 0.160 |
Why?
| Crosses, Genetic | 7 | 2006 | 140 | 0.160 |
Why?
| CD28 Antigens | 2 | 2008 | 48 | 0.160 |
Why?
| Case-Control Studies | 2 | 2020 | 3336 | 0.160 |
Why?
| Male | 30 | 2020 | 63248 | 0.160 |
Why?
| fas Receptor | 4 | 2002 | 96 | 0.160 |
Why?
| Adaptive Immunity | 2 | 2017 | 161 | 0.150 |
Why?
| Caspase 1 | 2 | 2009 | 143 | 0.150 |
Why?
| Mass Spectrometry | 3 | 2020 | 662 | 0.150 |
Why?
| Lymphocyte Count | 4 | 2010 | 149 | 0.150 |
Why?
| Trans-Activators | 2 | 2000 | 387 | 0.150 |
Why?
| Neoplasms | 3 | 2021 | 2429 | 0.150 |
Why?
| Mice, Inbred DBA | 19 | 2002 | 183 | 0.150 |
Why?
| Nickel | 2 | 2012 | 53 | 0.150 |
Why?
| Germinal Center | 2 | 2017 | 54 | 0.150 |
Why?
| Antigens, CD | 4 | 2000 | 480 | 0.150 |
Why?
| Dose-Response Relationship, Immunologic | 11 | 2000 | 82 | 0.150 |
Why?
| Immunotherapy | 3 | 2021 | 584 | 0.150 |
Why?
| Interferon Type I | 1 | 1999 | 138 | 0.150 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 154 | 0.150 |
Why?
| Complement C3b Inactivator Proteins | 1 | 2017 | 9 | 0.150 |
Why?
| Adoptive Transfer | 6 | 2015 | 217 | 0.150 |
Why?
| Receptors, Interferon | 2 | 2013 | 47 | 0.150 |
Why?
| Minor Histocompatibility Antigens | 2 | 2015 | 46 | 0.150 |
Why?
| Time Factors | 10 | 2013 | 6579 | 0.140 |
Why?
| CD4 Antigens | 9 | 1998 | 137 | 0.140 |
Why?
| Retinal Pigment Epithelium | 1 | 2017 | 68 | 0.140 |
Why?
| Complement Factor H | 1 | 2017 | 63 | 0.140 |
Why?
| Receptors, IgE | 1 | 1997 | 44 | 0.140 |
Why?
| Substrate Specificity | 1 | 2017 | 372 | 0.140 |
Why?
| Cats | 1 | 2017 | 211 | 0.130 |
Why?
| Blotting, Western | 3 | 2020 | 1189 | 0.130 |
Why?
| Complement Pathway, Alternative | 1 | 2017 | 114 | 0.130 |
Why?
| Mice, Inbred C3H | 8 | 1993 | 279 | 0.130 |
Why?
| Drug Contamination | 1 | 2016 | 53 | 0.130 |
Why?
| Phenotype | 9 | 2008 | 3062 | 0.130 |
Why?
| Lupus Nephritis | 4 | 2012 | 56 | 0.130 |
Why?
| Amino Acid Motifs | 6 | 2019 | 210 | 0.130 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 98 | 0.130 |
Why?
| Immunoconjugates | 1 | 1997 | 101 | 0.130 |
Why?
| HLA Antigens | 3 | 2013 | 236 | 0.130 |
Why?
| Hematopoiesis | 1 | 1997 | 184 | 0.130 |
Why?
| Graft Rejection | 3 | 2015 | 567 | 0.120 |
Why?
| Serum Albumin, Bovine | 5 | 2011 | 61 | 0.120 |
Why?
| Chemokine CCL19 | 1 | 2015 | 6 | 0.120 |
Why?
| Chemokine CCL21 | 1 | 2015 | 14 | 0.120 |
Why?
| Imidazoles | 1 | 2016 | 225 | 0.120 |
Why?
| Receptors, CCR7 | 1 | 2015 | 27 | 0.120 |
Why?
| Immunoglobulin Isotypes | 2 | 2008 | 36 | 0.120 |
Why?
| Down-Regulation | 3 | 2003 | 639 | 0.120 |
Why?
| Genetic Linkage | 8 | 2002 | 299 | 0.120 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 86 | 0.120 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 41 | 0.120 |
Why?
| Immunization | 8 | 2013 | 416 | 0.120 |
Why?
| Antiviral Agents | 1 | 2021 | 708 | 0.120 |
Why?
| Sequence Homology, Nucleic Acid | 7 | 1992 | 150 | 0.120 |
Why?
| Nicotine | 1 | 2017 | 303 | 0.120 |
Why?
| Thymoma | 4 | 2012 | 31 | 0.120 |
Why?
| Skin Transplantation | 1 | 2015 | 88 | 0.120 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1988 | 80 | 0.110 |
Why?
| Epithelium | 6 | 1997 | 312 | 0.110 |
Why?
| Macrophages, Alveolar | 1 | 2017 | 389 | 0.110 |
Why?
| Green Fluorescent Proteins | 3 | 2013 | 392 | 0.110 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 312 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 957 | 0.110 |
Why?
| Granuloma | 1 | 2014 | 88 | 0.110 |
Why?
| Hybridization, Genetic | 2 | 2014 | 79 | 0.110 |
Why?
| Organ Culture Techniques | 6 | 1993 | 145 | 0.110 |
Why?
| Molecular Weight | 11 | 2006 | 332 | 0.110 |
Why?
| Fluorescent Antibody Technique | 4 | 2004 | 392 | 0.110 |
Why?
| Chromosome Mapping | 8 | 2002 | 505 | 0.110 |
Why?
| Receptors, Interleukin-7 | 2 | 2006 | 27 | 0.110 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 391 | 0.110 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 376 | 0.110 |
Why?
| Conserved Sequence | 3 | 2009 | 228 | 0.110 |
Why?
| Heparin-binding EGF-like Growth Factor | 1 | 2013 | 11 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 3 | 2003 | 1974 | 0.110 |
Why?
| Lymphocytes, Null | 1 | 2012 | 2 | 0.100 |
Why?
| Antibodies, Viral | 1 | 2017 | 599 | 0.100 |
Why?
| Erythrocytes | 16 | 2002 | 669 | 0.100 |
Why?
| HLA-DR4 Antigen | 2 | 2005 | 79 | 0.100 |
Why?
| Kinetics | 13 | 2021 | 1622 | 0.100 |
Why?
| Diphtheria Toxin | 1 | 2013 | 56 | 0.100 |
Why?
| Minor Histocompatibility Loci | 2 | 1990 | 4 | 0.100 |
Why?
| Escherichia coli | 4 | 2013 | 784 | 0.100 |
Why?
| Age Factors | 4 | 2017 | 3137 | 0.100 |
Why?
| Cell Lineage | 2 | 2013 | 333 | 0.100 |
Why?
| Killer Cells, Natural | 2 | 2007 | 424 | 0.100 |
Why?
| Mice, Nude | 3 | 2013 | 680 | 0.100 |
Why?
| Genes, Immunoglobulin | 3 | 1988 | 28 | 0.100 |
Why?
| Hemocyanins | 8 | 1983 | 61 | 0.100 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 326 | 0.100 |
Why?
| DNA Primers | 1 | 2013 | 522 | 0.100 |
Why?
| Rhadinovirus | 1 | 2012 | 17 | 0.100 |
Why?
| Galactosylceramides | 2 | 2012 | 23 | 0.100 |
Why?
| Haplotypes | 4 | 1990 | 473 | 0.100 |
Why?
| Tumor Virus Infections | 1 | 2012 | 46 | 0.100 |
Why?
| Burkitt Lymphoma | 1 | 2012 | 55 | 0.100 |
Why?
| Immunophenotyping | 3 | 2004 | 311 | 0.100 |
Why?
| Mice, Inbred CBA | 8 | 1991 | 52 | 0.100 |
Why?
| Communicable Diseases | 1 | 1994 | 141 | 0.100 |
Why?
| Virus Diseases | 2 | 1992 | 207 | 0.100 |
Why?
| Dermatitis, Allergic Contact | 1 | 2012 | 70 | 0.090 |
Why?
| Ubiquitination | 2 | 2008 | 96 | 0.090 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2007 | 64 | 0.090 |
Why?
| Nucleocapsid Proteins | 1 | 2011 | 25 | 0.090 |
Why?
| Viral Core Proteins | 1 | 2011 | 21 | 0.090 |
Why?
| Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.090 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2011 | 16 | 0.090 |
Why?
| Surface Plasmon Resonance | 3 | 2021 | 87 | 0.090 |
Why?
| Salts | 1 | 2010 | 37 | 0.090 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 65 | 0.090 |
Why?
| Bone Marrow | 2 | 2009 | 262 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 7 | 2011 | 326 | 0.090 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.090 |
Why?
| Cell Line, Tumor | 4 | 2021 | 3114 | 0.090 |
Why?
| Structure-Activity Relationship | 8 | 2006 | 540 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 817 | 0.090 |
Why?
| Antibody Specificity | 7 | 1997 | 185 | 0.090 |
Why?
| HLA-DP Antigens | 1 | 2010 | 32 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2008 | 160 | 0.080 |
Why?
| Species Specificity | 10 | 2006 | 568 | 0.080 |
Why?
| Fibrin | 1 | 2010 | 70 | 0.080 |
Why?
| Recombinant Proteins | 7 | 2005 | 1306 | 0.080 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 6 | 1999 | 31 | 0.080 |
Why?
| Cattle | 2 | 2011 | 973 | 0.080 |
Why?
| Antigen-Antibody Reactions | 6 | 2021 | 51 | 0.080 |
Why?
| France | 1 | 2009 | 30 | 0.080 |
Why?
| Fibrinogen | 1 | 2010 | 159 | 0.080 |
Why?
| Molecular Docking Simulation | 2 | 2021 | 108 | 0.080 |
Why?
| Thrombin | 1 | 2010 | 146 | 0.080 |
Why?
| Injections, Intraperitoneal | 1 | 2009 | 106 | 0.080 |
Why?
| Retroviridae | 2 | 2013 | 96 | 0.080 |
Why?
| Antioxidants | 2 | 2003 | 559 | 0.080 |
Why?
| Antibodies, Neutralizing | 2 | 2022 | 258 | 0.080 |
Why?
| Aluminum Compounds | 1 | 2009 | 6 | 0.080 |
Why?
| Immunoglobulin Class Switching | 1 | 2009 | 15 | 0.080 |
Why?
| Phosphorylation | 4 | 2020 | 1686 | 0.080 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2009 | 20 | 0.080 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2011 | 225 | 0.080 |
Why?
| Antibody Affinity | 3 | 2005 | 58 | 0.080 |
Why?
| CD4-CD8 Ratio | 2 | 2002 | 22 | 0.080 |
Why?
| Integrin alpha4 | 1 | 2008 | 6 | 0.080 |
Why?
| Aged, 80 and over | 1 | 2020 | 7063 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.080 |
Why?
| Cell Adhesion Molecules | 1 | 1990 | 177 | 0.080 |
Why?
| Adsorption | 1 | 2009 | 138 | 0.080 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2008 | 13 | 0.080 |
Why?
| Liposomes | 3 | 2005 | 164 | 0.080 |
Why?
| History, 21st Century | 1 | 2009 | 183 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 3 | 2004 | 370 | 0.080 |
Why?
| Genes, Switch | 1 | 1988 | 6 | 0.080 |
Why?
| Chondroitin | 1 | 1988 | 5 | 0.080 |
Why?
| Cytoskeletal Proteins | 1 | 2009 | 141 | 0.080 |
Why?
| Protein Domains | 2 | 2020 | 243 | 0.080 |
Why?
| Antigens, Helminth | 1 | 2008 | 12 | 0.080 |
Why?
| Genes, Regulator | 1 | 1988 | 34 | 0.080 |
Why?
| Biomarkers | 1 | 2019 | 3878 | 0.070 |
Why?
| Schistosoma mansoni | 1 | 2008 | 37 | 0.070 |
Why?
| Histocompatibility Antigen H-2D | 3 | 2010 | 21 | 0.070 |
Why?
| Chondroitin Sulfates | 1 | 1988 | 34 | 0.070 |
Why?
| Methylation | 3 | 2018 | 228 | 0.070 |
Why?
| Polymerase Chain Reaction | 6 | 1997 | 1045 | 0.070 |
Why?
| Influenza Vaccines | 1 | 2013 | 544 | 0.070 |
Why?
| Biosensing Techniques | 1 | 2009 | 115 | 0.070 |
Why?
| Aged | 3 | 2020 | 22068 | 0.070 |
Why?
| Mice, Inbred AKR | 10 | 1989 | 35 | 0.070 |
Why?
| Transplantation Chimera | 3 | 2014 | 54 | 0.070 |
Why?
| Recombinant Fusion Proteins | 5 | 2002 | 642 | 0.070 |
Why?
| Infection Control | 1 | 2009 | 138 | 0.070 |
Why?
| Hybrid Cells | 4 | 1997 | 50 | 0.070 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 382 | 0.070 |
Why?
| Pancreas | 2 | 2021 | 307 | 0.070 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2007 | 33 | 0.070 |
Why?
| Fluoresceins | 2 | 2004 | 47 | 0.070 |
Why?
| Moths | 3 | 1997 | 38 | 0.070 |
Why?
| Immunoglobulin Fab Fragments | 2 | 2006 | 77 | 0.070 |
Why?
| In Vitro Techniques | 8 | 2000 | 1061 | 0.070 |
Why?
| Arthritis, Rheumatoid | 3 | 2005 | 1105 | 0.070 |
Why?
| Early Growth Response Protein 2 | 2 | 2018 | 10 | 0.070 |
Why?
| Health | 1 | 2007 | 74 | 0.070 |
Why?
| Poly I-C | 1 | 2006 | 62 | 0.070 |
Why?
| Chemokines | 1 | 2007 | 227 | 0.070 |
Why?
| Hyaluronan Receptors | 3 | 2003 | 93 | 0.070 |
Why?
| B-Cell Activating Factor | 1 | 2006 | 20 | 0.070 |
Why?
| Tissue Distribution | 3 | 1993 | 295 | 0.060 |
Why?
| Arginine | 2 | 2018 | 254 | 0.060 |
Why?
| Chemotaxis, Leukocyte | 2 | 2003 | 137 | 0.060 |
Why?
| Leukopoiesis | 1 | 2006 | 11 | 0.060 |
Why?
| Transgenes | 2 | 1997 | 180 | 0.060 |
Why?
| Spodoptera | 2 | 2021 | 37 | 0.060 |
Why?
| Peptide Hydrolases | 1 | 2006 | 109 | 0.060 |
Why?
| Promoter Regions, Genetic | 4 | 2020 | 1195 | 0.060 |
Why?
| Caspases | 2 | 2014 | 248 | 0.060 |
Why?
| Cell Fusion | 4 | 1989 | 51 | 0.060 |
Why?
| Protein Structure, Secondary | 4 | 2012 | 335 | 0.060 |
Why?
| HLA-D Antigens | 2 | 1998 | 34 | 0.060 |
Why?
| Insulin-Secreting Cells | 1 | 2010 | 363 | 0.060 |
Why?
| Enzyme Activation | 3 | 2008 | 811 | 0.060 |
Why?
| Sheep | 11 | 1983 | 832 | 0.060 |
Why?
| Prostaglandins E | 1 | 1985 | 47 | 0.060 |
Why?
| Leukemia P388 | 2 | 1984 | 7 | 0.060 |
Why?
| Proteolysis | 2 | 2018 | 162 | 0.060 |
Why?
| Models, Biological | 3 | 2001 | 1704 | 0.060 |
Why?
| Lymphocyte Depletion | 4 | 2001 | 130 | 0.060 |
Why?
| Succinimides | 1 | 2004 | 16 | 0.060 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 76 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 9 | 0.060 |
Why?
| MAP Kinase Kinase Kinases | 2 | 2008 | 70 | 0.060 |
Why?
| Phosphatidylserines | 1 | 2005 | 89 | 0.060 |
Why?
| Vaccinia virus | 2 | 2001 | 43 | 0.060 |
Why?
| Plasmids | 4 | 2001 | 358 | 0.060 |
Why?
| Tumor Cells, Cultured | 4 | 2001 | 929 | 0.060 |
Why?
| DNA, Complementary | 1 | 2004 | 270 | 0.060 |
Why?
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| Young Adult | 1 | 2020 | 12310 | 0.060 |
Why?
| Phosphoserine | 1 | 2004 | 31 | 0.060 |
Why?
| Antigens, Differentiation | 2 | 1997 | 82 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1950 | 0.060 |
Why?
| Fetus | 4 | 2014 | 764 | 0.060 |
Why?
| Fibroblasts | 3 | 2017 | 946 | 0.060 |
Why?
| Leukemia, Experimental | 1 | 1983 | 27 | 0.060 |
Why?
| Receptors, Leukotriene B4 | 1 | 2003 | 6 | 0.060 |
Why?
| Lung | 4 | 2014 | 3925 | 0.050 |
Why?
| Leukotriene B4 | 1 | 2003 | 41 | 0.050 |
Why?
| Catalase | 1 | 2003 | 123 | 0.050 |
Why?
| Luminescent Proteins | 2 | 2001 | 180 | 0.050 |
Why?
| Chromosome Deletion | 4 | 1991 | 104 | 0.050 |
Why?
| Selection, Genetic | 2 | 2019 | 250 | 0.050 |
Why?
| Bone Marrow Transplantation | 3 | 2014 | 267 | 0.050 |
Why?
| RNA | 3 | 2003 | 877 | 0.050 |
Why?
| Antibody-Producing Cells | 7 | 1983 | 30 | 0.050 |
Why?
| Fas Ligand Protein | 1 | 2003 | 59 | 0.050 |
Why?
| Incidence | 1 | 2010 | 2635 | 0.050 |
Why?
| Protein Biosynthesis | 3 | 1992 | 409 | 0.050 |
Why?
| Myeloid Cells | 1 | 2004 | 140 | 0.050 |
Why?
| Solubility | 4 | 1998 | 233 | 0.050 |
Why?
| Fluorescent Dyes | 2 | 2001 | 319 | 0.050 |
Why?
| Binding Sites, Antibody | 5 | 1991 | 42 | 0.050 |
Why?
| Antigens, Ly | 4 | 1988 | 46 | 0.050 |
Why?
| Interleukin-1 | 5 | 1997 | 972 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 129 | 0.050 |
Why?
| Drug Evaluation, Preclinical | 1 | 2002 | 174 | 0.050 |
Why?
| Sequence Alignment | 2 | 2008 | 333 | 0.050 |
Why?
| Mesencephalon | 1 | 2002 | 66 | 0.050 |
Why?
| Synovial Fluid | 2 | 2000 | 66 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 163 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 517 | 0.050 |
Why?
| Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| Chronic Disease | 3 | 2013 | 1717 | 0.050 |
Why?
| Transplantation, Heterologous | 1 | 2002 | 190 | 0.050 |
Why?
| Crystallization | 2 | 2015 | 136 | 0.050 |
Why?
| Interphase | 2 | 2000 | 31 | 0.050 |
Why?
| Sex Chromosome Aberrations | 1 | 1981 | 63 | 0.050 |
Why?
| Hemolytic Plaque Technique | 10 | 1983 | 28 | 0.050 |
Why?
| Calcium | 6 | 2004 | 1175 | 0.050 |
Why?
| Growth Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| Borrelia burgdorferi Group | 1 | 2000 | 9 | 0.040 |
Why?
| CD40 Antigens | 1 | 2001 | 88 | 0.040 |
Why?
| Melanoma, Experimental | 1 | 2001 | 107 | 0.040 |
Why?
| Temperature | 1 | 2003 | 635 | 0.040 |
Why?
| Phagocytosis | 1 | 2002 | 363 | 0.040 |
Why?
| Receptors, Virus | 1 | 2021 | 81 | 0.040 |
Why?
| Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.040 |
Why?
| Immunosuppressive Agents | 1 | 2005 | 699 | 0.040 |
Why?
| Up-Regulation | 1 | 2003 | 850 | 0.040 |
Why?
| Nucleic Acid Hybridization | 2 | 1999 | 191 | 0.040 |
Why?
| Antibody Diversity | 3 | 1989 | 16 | 0.040 |
Why?
| Phorbol Esters | 1 | 2000 | 15 | 0.040 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 11 | 0.040 |
Why?
| Lymphocyte Culture Test, Mixed | 3 | 1990 | 48 | 0.040 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2000 | 60 | 0.040 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 41 | 0.040 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 20 | 0.040 |
Why?
| Haploidy | 1 | 1980 | 24 | 0.040 |
Why?
| Receptors, Interleukin-6 | 1 | 2000 | 36 | 0.040 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2021 | 137 | 0.040 |
Why?
| Middle Aged | 2 | 2020 | 31024 | 0.040 |
Why?
| Jurkat Cells | 1 | 2000 | 136 | 0.040 |
Why?
| STAT1 Transcription Factor | 1 | 2000 | 69 | 0.040 |
Why?
| Cancer Vaccines | 1 | 2021 | 164 | 0.040 |
Why?
| Indicators and Reagents | 1 | 2000 | 108 | 0.040 |
Why?
| Rats | 5 | 2002 | 5254 | 0.040 |
Why?
| Cell Line, Transformed | 1 | 2000 | 140 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 107 | 0.040 |
Why?
| Lymphocyte Transfusion | 1 | 1999 | 20 | 0.040 |
Why?
| Leukemia L1210 | 1 | 1999 | 7 | 0.040 |
Why?
| Lipoproteins | 1 | 2000 | 170 | 0.040 |
Why?
| Haptens | 3 | 1988 | 21 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 2012 | 1424 | 0.040 |
Why?
| Recombination, Genetic | 4 | 1988 | 186 | 0.040 |
Why?
| Adult | 3 | 2020 | 35423 | 0.040 |
Why?
| Lymphopenia | 1 | 1999 | 60 | 0.040 |
Why?
| Free Radical Scavengers | 1 | 1999 | 81 | 0.040 |
Why?
| Chickens | 5 | 1994 | 188 | 0.040 |
Why?
| Peer Review, Research | 1 | 1999 | 40 | 0.040 |
Why?
| Manganese | 1 | 1999 | 61 | 0.040 |
Why?
| Cholic Acids | 1 | 1998 | 17 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 208 | 0.040 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 58 | 0.040 |
Why?
| Cell Cycle | 2 | 2020 | 582 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1999 | 122 | 0.040 |
Why?
| Detergents | 1 | 1998 | 45 | 0.040 |
Why?
| Metalloporphyrins | 1 | 1999 | 106 | 0.040 |
Why?
| Nucleosomes | 1 | 2020 | 135 | 0.040 |
Why?
| Membrane Potentials | 1 | 1999 | 261 | 0.040 |
Why?
| Coculture Techniques | 2 | 2013 | 219 | 0.040 |
Why?
| Trinitrobenzenes | 5 | 1982 | 14 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 2 | 2005 | 138 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 2000 | 187 | 0.040 |
Why?
| Behavior, Animal | 1 | 2002 | 486 | 0.040 |
Why?
| Hot Temperature | 2 | 2000 | 362 | 0.040 |
Why?
| Neutrophils | 1 | 2004 | 1205 | 0.040 |
Why?
| Lymphoma | 5 | 1985 | 190 | 0.040 |
Why?
| Crystallography | 2 | 2007 | 25 | 0.040 |
Why?
| Mice, Inbred A | 6 | 1984 | 49 | 0.040 |
Why?
| NFATC Transcription Factors | 1 | 2018 | 80 | 0.040 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 99 | 0.040 |
Why?
| Autophagosomes | 1 | 2017 | 19 | 0.040 |
Why?
| Recovery of Function | 1 | 2002 | 642 | 0.040 |
Why?
| Endocytosis | 1 | 1998 | 162 | 0.040 |
Why?
| Nicotinic Antagonists | 1 | 2017 | 33 | 0.040 |
Why?
| STAT6 Transcription Factor | 1 | 1997 | 25 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 348 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 1999 | 305 | 0.040 |
Why?
| Dinoprostone | 2 | 1991 | 188 | 0.040 |
Why?
| Neoplasm Transplantation | 2 | 2012 | 255 | 0.040 |
Why?
| Oligonucleotides | 2 | 2004 | 140 | 0.040 |
Why?
| Mutagenesis | 2 | 2013 | 179 | 0.040 |
Why?
| Abatacept | 1 | 1997 | 47 | 0.030 |
Why?
| Columbidae | 2 | 1994 | 30 | 0.030 |
Why?
| Receptors, Complement | 1 | 2017 | 120 | 0.030 |
Why?
| Societies, Medical | 1 | 2001 | 760 | 0.030 |
Why?
| Interleukins | 1 | 1999 | 245 | 0.030 |
Why?
| Phylogeny | 1 | 2021 | 844 | 0.030 |
Why?
| Immunomodulation | 1 | 2017 | 90 | 0.030 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 159 | 0.030 |
Why?
| CTLA-4 Antigen | 1 | 1997 | 88 | 0.030 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 57 | 0.030 |
Why?
| Amino Acid Substitution | 1 | 1997 | 283 | 0.030 |
Why?
| Respiratory Hypersensitivity | 1 | 1997 | 64 | 0.030 |
Why?
| Parkinson Disease | 1 | 2002 | 410 | 0.030 |
Why?
| Germ-Line Mutation | 2 | 2009 | 140 | 0.030 |
Why?
| Gene Deletion | 2 | 2009 | 375 | 0.030 |
Why?
| Protein Subunits | 1 | 2017 | 232 | 0.030 |
Why?
| Genetic Complementation Test | 2 | 1986 | 63 | 0.030 |
Why?
| Hemolysis | 1 | 2017 | 199 | 0.030 |
Why?
| Immunity, Mucosal | 1 | 1997 | 87 | 0.030 |
Why?
| Molecular Conformation | 2 | 2009 | 141 | 0.030 |
Why?
| Sequence Homology | 1 | 1995 | 40 | 0.030 |
Why?
| Nitrophenols | 4 | 2004 | 33 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 3 | 2003 | 542 | 0.030 |
Why?
| Molecular Structure | 2 | 2003 | 469 | 0.030 |
Why?
| Epitope Mapping | 2 | 2011 | 58 | 0.030 |
Why?
| Immunoglobulins | 2 | 1987 | 158 | 0.030 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| Histocompatibility Testing | 1 | 2015 | 122 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 265 | 0.030 |
Why?
| gamma-Globulins | 4 | 1983 | 18 | 0.030 |
Why?
| Antilymphocyte Serum | 8 | 1981 | 63 | 0.030 |
Why?
| Insecta | 2 | 2006 | 66 | 0.030 |
Why?
| Receptors, Nicotinic | 1 | 2017 | 323 | 0.030 |
Why?
| Immunoglobulin E | 2 | 1997 | 353 | 0.030 |
Why?
| Protein Transport | 2 | 2008 | 424 | 0.030 |
Why?
| V(D)J Recombination | 1 | 2014 | 6 | 0.030 |
Why?
| Peptide Biosynthesis | 1 | 1994 | 13 | 0.030 |
Why?
| Databases, Factual | 1 | 2000 | 1289 | 0.030 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 35 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 160 | 0.030 |
Why?
| Cell Adhesion | 3 | 1999 | 452 | 0.030 |
Why?
| Horses | 4 | 1981 | 104 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 382 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 143 | 0.030 |
Why?
| Cysteine | 2 | 2010 | 190 | 0.030 |
Why?
| Transplantation, Homologous | 1 | 2015 | 404 | 0.030 |
Why?
| Disulfides | 2 | 1984 | 95 | 0.030 |
Why?
| Transferrin | 1 | 1993 | 42 | 0.030 |
Why?
| Transplantation Immunology | 1 | 1993 | 33 | 0.030 |
Why?
| Cell Transplantation | 1 | 1993 | 35 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 357 | 0.030 |
Why?
| Multigene Family | 2 | 1991 | 197 | 0.030 |
Why?
| Sodium | 1 | 2014 | 205 | 0.030 |
Why?
| Trypsin | 4 | 2006 | 73 | 0.030 |
Why?
| Hydrogen Bonding | 2 | 2008 | 149 | 0.030 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 182 | 0.030 |
Why?
| Viral Envelope Proteins | 1 | 1994 | 86 | 0.030 |
Why?
| Endopeptidase K | 1 | 2013 | 15 | 0.030 |
Why?
| United States | 3 | 2015 | 13992 | 0.030 |
Why?
| Interleukin-2 Receptor beta Subunit | 1 | 2013 | 18 | 0.030 |
Why?
| Blotting, Southern | 1 | 1993 | 69 | 0.030 |
Why?
| Growth Substances | 2 | 1983 | 155 | 0.030 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 36 | 0.030 |
Why?
| HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 25 | 0.030 |
Why?
| Vomiting | 1 | 1993 | 129 | 0.030 |
Why?
| Hepatocytes | 1 | 2014 | 215 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 613 | 0.030 |
Why?
| Mice, Inbred MRL lpr | 1 | 2012 | 38 | 0.020 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 111 | 0.020 |
Why?
| Embryonic and Fetal Development | 1 | 1992 | 95 | 0.020 |
Why?
| Perissodactyla | 4 | 1981 | 12 | 0.020 |
Why?
| Intestinal Mucosa | 1 | 1997 | 570 | 0.020 |
Why?
| Disease | 1 | 1993 | 95 | 0.020 |
Why?
| Immunoassay | 2 | 1989 | 101 | 0.020 |
Why?
| Ionomycin | 1 | 1991 | 24 | 0.020 |
Why?
| DNA Methylation | 1 | 1996 | 602 | 0.020 |
Why?
| DNA, Recombinant | 3 | 2005 | 46 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1991 | 150 | 0.020 |
Why?
| Oligonucleotides, Antisense | 1 | 1992 | 106 | 0.020 |
Why?
| Tumor Burden | 1 | 2012 | 284 | 0.020 |
Why?
| Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| Cellular Senescence | 1 | 1993 | 176 | 0.020 |
Why?
| Genotype | 1 | 1996 | 1835 | 0.020 |
Why?
| Mice, Inbred NZB | 2 | 2007 | 15 | 0.020 |
Why?
| Analysis of Variance | 1 | 2014 | 1285 | 0.020 |
Why?
| Glycosylation | 4 | 1994 | 144 | 0.020 |
Why?
| Blotting, Northern | 1 | 1991 | 202 | 0.020 |
Why?
| Immunotherapy, Adoptive | 1 | 1993 | 288 | 0.020 |
Why?
| Mutant Chimeric Proteins | 1 | 2010 | 3 | 0.020 |
Why?
| Pregnancy | 2 | 2014 | 6256 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1992 | 324 | 0.020 |
Why?
| Lysine | 1 | 2012 | 266 | 0.020 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.020 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 6 | 0.020 |
Why?
| Depression, Chemical | 1 | 1990 | 22 | 0.020 |
Why?
| RNA Splicing | 1 | 1991 | 254 | 0.020 |
Why?
| Kidney Diseases | 1 | 2014 | 366 | 0.020 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 54 | 0.020 |
Why?
| Milk | 1 | 1991 | 129 | 0.020 |
Why?
| Epoprostenol | 1 | 1991 | 135 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 53 | 0.020 |
Why?
| Amidohydrolases | 1 | 1990 | 30 | 0.020 |
Why?
| Smoking | 1 | 2017 | 1501 | 0.020 |
Why?
| Restriction Mapping | 3 | 1998 | 77 | 0.020 |
Why?
| Multiprotein Complexes | 1 | 2011 | 147 | 0.020 |
Why?
| Histidine | 2 | 2003 | 61 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2013 | 492 | 0.020 |
Why?
| Precipitin Tests | 2 | 1991 | 94 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 480 | 0.020 |
Why?
| Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 13 | 0.020 |
Why?
| Gestational Age | 1 | 1992 | 857 | 0.020 |
Why?
| Homozygote | 1 | 1989 | 192 | 0.020 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 34 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 45 | 0.020 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 31 | 0.020 |
Why?
| Eosinophils | 2 | 2004 | 324 | 0.020 |
Why?
| Animals, Newborn | 2 | 1988 | 817 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 142 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2008 | 83 | 0.020 |
Why?
| Immune Sera | 2 | 2005 | 88 | 0.020 |
Why?
| Shock, Septic | 1 | 1990 | 204 | 0.020 |
Why?
| Microspheres | 1 | 1988 | 123 | 0.020 |
Why?
| Immunoblotting | 1 | 2008 | 302 | 0.020 |
Why?
| Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| Glutamic Acid | 1 | 2010 | 231 | 0.020 |
Why?
| Treatment Outcome | 1 | 2002 | 10256 | 0.020 |
Why?
| Mice, Congenic | 1 | 2007 | 22 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 120 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2008 | 104 | 0.020 |
Why?
| Leukocyte Count | 1 | 1988 | 328 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2007 | 58 | 0.020 |
Why?
| Biological Transport | 2 | 1999 | 394 | 0.020 |
Why?
| Epithelial Cells | 1 | 1993 | 1063 | 0.020 |
Why?
| Cytoplasm | 2 | 2004 | 260 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 52 | 0.020 |
Why?
| Weight Loss | 1 | 1992 | 724 | 0.020 |
Why?
| Immunoglobulin gamma-Chains | 1 | 1986 | 3 | 0.020 |
Why?
| Antibodies, Antinuclear | 1 | 2006 | 64 | 0.020 |
Why?
| Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| Proteinuria | 1 | 2006 | 89 | 0.020 |
Why?
| Proteins | 2 | 1982 | 945 | 0.020 |
Why?
| Glass | 1 | 1986 | 43 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2006 | 106 | 0.020 |
Why?
| Liver | 2 | 1992 | 1835 | 0.020 |
Why?
| Body Weight | 1 | 1990 | 936 | 0.020 |
Why?
| Mast-Cell Sarcoma | 1 | 1985 | 4 | 0.020 |
Why?
| Transformation, Genetic | 1 | 1985 | 16 | 0.020 |
Why?
| Liver Transplantation | 1 | 1992 | 801 | 0.020 |
Why?
| Cricetinae | 3 | 1994 | 275 | 0.020 |
Why?
| Prevalence | 1 | 2012 | 2541 | 0.010 |
Why?
| Stereoisomerism | 1 | 2005 | 98 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 2005 | 145 | 0.010 |
Why?
| Freund's Adjuvant | 1 | 2004 | 17 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 365 | 0.010 |
Why?
| Rosette Formation | 2 | 1980 | 16 | 0.010 |
Why?
| Isoelectric Point | 1 | 1984 | 23 | 0.010 |
Why?
| Genetic Markers | 1 | 1985 | 336 | 0.010 |
Why?
| Isoelectric Focusing | 1 | 1983 | 34 | 0.010 |
Why?
| Gene Library | 1 | 2004 | 118 | 0.010 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 183 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 149 | 0.010 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 151 | 0.010 |
Why?
| Receptors, CCR5 | 1 | 2003 | 58 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 37 | 0.010 |
Why?
| Birds | 1 | 1983 | 74 | 0.010 |
Why?
| Karyotyping | 1 | 1983 | 107 | 0.010 |
Why?
| Phosphates | 1 | 2004 | 168 | 0.010 |
Why?
| Rabbits | 3 | 1984 | 757 | 0.010 |
Why?
| Phosphoproteins | 1 | 2005 | 326 | 0.010 |
Why?
| Lod Score | 1 | 2002 | 66 | 0.010 |
Why?
| Oxidopamine | 1 | 2002 | 13 | 0.010 |
Why?
| Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| Sympatholytics | 1 | 2002 | 14 | 0.010 |
Why?
| Transplantation, Heterotopic | 1 | 2002 | 17 | 0.010 |
Why?
| DNA, Viral | 1 | 2004 | 380 | 0.010 |
Why?
| Interleukin-5 | 1 | 1982 | 38 | 0.010 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2002 | 74 | 0.010 |
Why?
| X Chromosome | 1 | 1981 | 51 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 422 | 0.010 |
Why?
| Immunoglobulin Constant Regions | 3 | 1986 | 7 | 0.010 |
Why?
| DNA Restriction Enzymes | 3 | 1986 | 56 | 0.010 |
Why?
| Thymectomy | 3 | 1975 | 15 | 0.010 |
Why?
| Methamphetamine | 1 | 2002 | 57 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 296 | 0.010 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 576 | 0.010 |
Why?
| Chromatography, Gel | 2 | 1983 | 125 | 0.010 |
Why?
| Genes, Reporter | 1 | 2001 | 269 | 0.010 |
Why?
| Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 778 | 0.010 |
Why?
| Biopolymers | 1 | 2000 | 32 | 0.010 |
Why?
| Bacterial Vaccines | 1 | 2000 | 62 | 0.010 |
Why?
| Corpus Striatum | 1 | 2002 | 153 | 0.010 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| HLA-DRB1 Chains | 1 | 2000 | 107 | 0.010 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| Lyme Disease | 1 | 2000 | 54 | 0.010 |
Why?
| Genes, Dominant | 1 | 1999 | 92 | 0.010 |
Why?
| Staining and Labeling | 1 | 1980 | 142 | 0.010 |
Why?
| Androstadienes | 1 | 1999 | 107 | 0.010 |
Why?
| Immunization, Secondary | 1 | 1999 | 88 | 0.010 |
Why?
| Public Policy | 1 | 1999 | 69 | 0.010 |
Why?
| Computer Simulation | 1 | 2003 | 943 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 155 | 0.010 |
Why?
| Dopamine | 1 | 2002 | 281 | 0.010 |
Why?
| Half-Life | 2 | 1977 | 148 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 185 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 268 | 0.010 |
Why?
| Cartilage | 1 | 2000 | 181 | 0.010 |
Why?
| Asparagine | 1 | 1998 | 29 | 0.010 |
Why?
| Polysaccharides, Bacterial | 2 | 1975 | 67 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 1999 | 312 | 0.010 |
Why?
| Histocompatibility | 1 | 1977 | 26 | 0.010 |
Why?
| Codon | 1 | 1998 | 88 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1999 | 404 | 0.010 |
Why?
| Collagen | 1 | 2000 | 433 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 1697 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 361 | 0.010 |
Why?
| Dimerization | 1 | 1997 | 189 | 0.010 |
Why?
| Warfarin | 1 | 1978 | 150 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2002 | 2311 | 0.010 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 84 | 0.010 |
Why?
| Research | 1 | 1999 | 413 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 829 | 0.010 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1996 | 70 | 0.010 |
Why?
| Radiation Effects | 1 | 1975 | 4 | 0.010 |
Why?
| Absorption | 1 | 1975 | 57 | 0.010 |
Why?
| Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| Surface Properties | 1 | 1976 | 391 | 0.010 |
Why?
| Trachea | 1 | 1997 | 228 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1994 | 72 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 82 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 344 | 0.010 |
Why?
| Golgi Apparatus | 1 | 1994 | 100 | 0.010 |
Why?
| Umbilical Cord | 1 | 1994 | 84 | 0.010 |
Why?
| Immunologic Techniques | 2 | 1983 | 39 | 0.010 |
Why?
| Neurons | 1 | 2002 | 1437 | 0.010 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1983 | 56 | 0.010 |
Why?
| Pedigree | 1 | 1994 | 491 | 0.010 |
Why?
| Macaca mulatta | 1 | 1993 | 154 | 0.010 |
Why?
| Genetic Variation | 2 | 1990 | 935 | 0.010 |
Why?
| Microsomes | 1 | 1992 | 31 | 0.010 |
Why?
| Drug Synergism | 2 | 1983 | 354 | 0.010 |
Why?
| Zinc | 1 | 1995 | 291 | 0.010 |
Why?
| Models, Structural | 1 | 1991 | 40 | 0.010 |
Why?
| Methionine | 1 | 1992 | 158 | 0.010 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| Calcimycin | 1 | 1991 | 48 | 0.010 |
Why?
| Carbohydrates | 1 | 1991 | 62 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 918 | 0.010 |
Why?
| Arthritis | 1 | 1991 | 114 | 0.010 |
Why?
| Genes, MHC Class I | 1 | 1990 | 33 | 0.010 |
Why?
| Cricetulus | 1 | 1989 | 101 | 0.000 |
Why?
| Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.000 |
Why?
| Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.000 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 16 | 0.000 |
Why?
| Phosphorylcholine | 1 | 1988 | 18 | 0.000 |
Why?
| Reference Values | 1 | 1990 | 791 | 0.000 |
Why?
| Extracellular Space | 1 | 1989 | 124 | 0.000 |
Why?
| Cross-Linking Reagents | 1 | 1989 | 200 | 0.000 |
Why?
| Bacteriophage lambda | 1 | 1988 | 85 | 0.000 |
Why?
| Mannose | 1 | 1987 | 24 | 0.000 |
Why?
| Hexosaminidases | 1 | 1987 | 18 | 0.000 |
Why?
| Introns | 1 | 1988 | 242 | 0.000 |
Why?
| Exons | 1 | 1988 | 332 | 0.000 |
Why?
| Oligosaccharides | 1 | 1987 | 57 | 0.000 |
Why?
| Enhancer Elements, Genetic | 1 | 1988 | 178 | 0.000 |
Why?
| Pepsin A | 1 | 1986 | 19 | 0.000 |
Why?
| Hypersensitivity, Delayed | 2 | 1978 | 28 | 0.000 |
Why?
| Vinblastine | 2 | 1976 | 69 | 0.000 |
Why?
| Staphylococcal Infections | 1 | 1990 | 385 | 0.000 |
Why?
| Immunoglobulin J-Chains | 1 | 1985 | 6 | 0.000 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 210 | 0.000 |
Why?
| Genetic Code | 1 | 1985 | 21 | 0.000 |
Why?
| Protein Denaturation | 1 | 1984 | 73 | 0.000 |
Why?
| Immunoglobulin Light Chains | 1 | 1984 | 39 | 0.000 |
Why?
| Membranes, Artificial | 1 | 1984 | 68 | 0.000 |
Why?
| Albumins | 1 | 1984 | 102 | 0.000 |
Why?
| Thymus Neoplasms | 1 | 1984 | 22 | 0.000 |
Why?
| Bacteria | 1 | 1991 | 812 | 0.000 |
Why?
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.000 |
Why?
| Fixatives | 1 | 1983 | 15 | 0.000 |
Why?
| Cell-Free System | 1 | 1983 | 48 | 0.000 |
Why?
| Glutaral | 1 | 1983 | 15 | 0.000 |
Why?
| Receptors, Antigen | 1 | 1983 | 14 | 0.000 |
Why?
| Longitudinal Studies | 1 | 1990 | 2670 | 0.000 |
Why?
| Cell Nucleus | 1 | 1985 | 571 | 0.000 |
Why?
| Fetal Blood | 1 | 1983 | 315 | 0.000 |
Why?
| Pulmonary Alveoli | 1 | 1983 | 404 | 0.000 |
Why?
| Polymers | 1 | 1983 | 475 | 0.000 |
Why?
| Isoantigens | 1 | 1977 | 14 | 0.000 |
Why?
| Skin Tests | 1 | 1975 | 126 | 0.000 |
Why?
| Child | 1 | 1994 | 20860 | 0.000 |
Why?
| Immunoglobulin M | 1 | 1975 | 268 | 0.000 |
Why?
|
|
Marrack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|